l carnitine huberman L-Carnitine Insights What are the benefits of
Description
Pharmacological treatment of Parkinson disease
Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome
Monina N
Milara, J., Roger, I., Montero, P., Artigues, E., Escriv, J., & Cortijo, J
In summary, the available evidence states a model in which PM 2.5 exposure is not a universal asthma risk factor but rather a conditionally harmful exposure whose effects are increased by specific genetic backgrounds, mostly involving detoxification capacity ( GSTP1, GSTM1 ) and the 17q1221 susceptibility locus
Ohtake Y, Watanabe K, Tezuka H, Ogata T, Yabuuchi S, Murata K, et al
